Search results
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters· 3 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
Reuters via Yahoo Finance UK· 3 days agoAstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based...
Astra’s RSV Shot for Babies Likely Too Pricey For UK’s NHS
Bloomberg· 3 days agoThe UK’s decision not to provide babies with a shot against RSV is likely driven in part by cost...
MARKET REPORT: Nvidia shares recover after $577bn sell-off
This Is Money· 4 days agoShares in artificial intelligence chip designer Nvidia rose nearly 6 per cent after a three-day rout...
FTSE 100 movers: Admiral boosted by upgrade; Melrose, Rolls-Royce slump
ShareCast· 4 days agoLondon’s FTSE 100 was down 0.3% at 8,258.89 in afternoon trade on Tuesday.
London close: Stocks finish lower after Airbus profit warning
ShareCast· 4 days agoLondon stocks ended Tuesday in negative territory, influenced by significant losses in key sectors...
Is the AI bubble about to burst?
The Independent· 4 days agoThe US chip manufacturer has had more than $550bn (£433bn) wiped from its value since the sellers got to work and blew the top off its Thursday peak. To...
AstraZeneca still a buy for one broker despite mixed Imfinzi data
Proactive Financial News· 4 days agoAstraZeneca PLC (LSE:AZN) has put out mixed data for the Phase III trials of its immuno-oncology...
AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung...
Benzinga via Yahoo Finance UK· 4 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3...
London midday: Stocks fall as Rolls-Royce, Melrose hit by Airbus warning
ShareCast· 4 days agoLondon stocks had fallen into the red by midday on Tuesday, with Rolls-Royce and Melrose pacing the...